Skip NavigationSkip to Content

Boundary Layer Infusion of Nitric Oxide Reduces Early Smooth Muscle Cell Proliferation in the Endarterectomized Canine Artery

  1. Author:
    Chen, C. Y.
    Hanson, S. R.
    Keefer, L. K.
    Saavedra, J. E.
    Davies, K. M.
    Hutsell, T. C.
    Hughes, J. D.
    Ku, D. N.
    Lumsden, A. B.
  2. Author Address

    Lumsden AB 1364 CLIFTON RD NE BOX M-11 ATLANTA, GA 30322 USA VET AFFAIRS MED CTR DEPT SURG DECATUR, GA 30033 USA EMORY UNIV SCH MED ATLANTA, GA 30322 USA NCI FREDERICK CANC RES & DEV CTR FREDERICK, MD 21702 USA GEORGE MASON UNIV DEPT CHEM FAIRFAX, VA 22030 USA COMEDICUS INC COLUMBIA HTS, MN 55421 USA
    1. Year: 1997
  1. Journal: Journal of Surgical Research
    1. 67
    2. 1
    3. Pages: 26-32
  2. Type of Article: Article
  1. Abstract:

    To evaluate the direct effect of nitric oxide (NO) on vascular smooth muscle cell (SMC) proliferation in vivo, we used an expanded polytetrafluoroethylene (ePTFE)-based local infusion device to deliver an NO donor, proline/NO (PROLI/NO), to the luminal boundary layer of endarterectomized artery and the distal anastomosis of the graft in a canine model. Once delivered to the blood, PROLI/NO releases NO by a mechanism involving pH-dependent decomposition. Six dogs underwent bilateral femoral artery endarterectomies. ePTFE infusion devices, blindly primed with PROLI/NO to one artery or proline to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. PROLI/NO or proline was continuously delivered for 7 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 7 days, and the processed specimens were blindly analyzed for SMC proliferation at both graft anastomoses and endarterectomized segments by a bromodeoxyuridine index assay. All dogs survived with no clinical side effects. In comparing the treated and control vessels, NO released from PROLI/NO significantly reduced SMC proliferation by 43% (13.24 +/- 1.24% versus 23.24 +/- 1.01%, P = 0.004) at the distal anastomoses and by 68% (10.58 +/- 1.63% versus 25.17 +/- 3.39%, P = 0.007) at endarterectomized segments. However, there was no significant difference in blood flow measurements between treated and control arteries (56.25 +/- 6.50 ml/min versus 46.50 +/- 3.20 ml/min, P = 0.094). These data demonstrate that local boundary layer infusion of NO released from PROLI/NO significantly reduces SMC proliferation in injured arteries with no effect on regional blood flow. This study suggests a new strategy to inhibit early SMC proliferation in injured arteries and probably to control intimal hyperplastic lesion formation in the manipulated vessels. (C) 1997 Academic Press. [References: 41]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel